Novartis AG

Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study (2015) Bergmann L, Kube U, Doehn C, Steiner T, Goebell P, Kindler M, Herrmann E, et al. Journal article The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation (2015) Zaiss M, Rapin A, Lebon L, Dubey LK, Mosconi I, Sarter K, Piersigilli A, et al. Journal article Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry (2015) Schmieder R, Gitt AK, Koch C, Bramlage P, Ouarrak T, Tschoepe D Journal article The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry (2015) Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, et al. Journal article Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study (2015) Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A Journal article Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? (2015) Roemer F, Kwoh CK, Hannon MJ, Hunter DJ, Eckstein F, Wang Z, Boudreau RM, et al. Journal article Ligand-Biased and Probe-Dependent Modulation of Chemokine Receptor CXCR3 Signaling by Negative Allosteric Modulators (2015) Bernat V, Brox R, Heinrich M, Auberson YP, Tschammer N Journal article, Original article Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer (2014) Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, et al. Journal article Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study (2014) Fasching P, Fehm T, Kellner S, De Waal J, Rezal M, Baler B, Baake G, et al. Journal article FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) Fasching P, Jud S, Hauschild M, Kuemmel S, Schuette M, Warm M, Hanf V, et al. Journal article